Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2018 December;60(4) > Panminerva Medica 2018 December;60(4):228-30

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

LETTERS TO THE EDITOR   

Panminerva Medica 2018 December;60(4):228-30

DOI: 10.23736/S0031-0808.18.03468-7

Copyright © 2018 EDIZIONI MINERVA MEDICA

lingua: Inglese

Tetrahydrocannabinol: a drug of interest

Juhi TIWARI 1, Kartikey BAJPAI 2, Gaurav GUPTA 1 , Rahul SHARMA 1, Rajesh K. VERMA 1, Kamal DUA 3, 4, 5

1 School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, India; 2 MET IIT College Bandra, Mumbai, India; 3 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia; 4 School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia; 5 Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, Australia



inizio pagina